general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 


Understanding Prostate Diseases
Doc, I've Been Wondering...
   
     
 

How many times have you left a doctor's appointment and said, "I meant to ask something, but forgot."

At Bayer, we know it is sometimes difficult to remember all the questions you have for your doctor when you are in the office. We have compiled a list of some of the questions you might consider asking during your next visit to the doctor. We invite you to print a copy to take with you. A few lines are left blank so you can write in additional questions of your own.


What tests are used to detect prostate cancer?

What is prostate specific antigen (PSA)?

There is a history of prostate cancer in my family. Am I at increased risk?

What is the clinical stage and grade of my cancer? What do these mean in my case?

What is my expected survival rate based on clinical stage, grade, and various treatment options?

Does testosterone cause prostate cancer?

What therapies are used to treat prostate cancer? Which do you recommend and why?

What are the side effects of the different treatments?

As a result of treatment, will I have urinary or rectal problems, such as incontinence or impotence? How are these problems treated?

With the treatments we discussed, how likely is it I will have a recurrence of my cancer?

How will a particular treatment affect my quality of life?

Where can I find additional information about prostate cancer and treatments?

Are there any prostate cancer support groups for me (or for my partner/family) in our area?

Are there things I should not do before or after treatment?

Should I follow a special diet?

Are there any medications I should avoid while receiving treatment?

What are my next steps?

 
Printer-Friendly Version
 
PSA Tracking Chart
 
Our Continuous Care Program
Year-Long Support to Help you Stay on Track
 
Helpful Links
 
Tips for Caretakers

Important Safety Considerations
Viadur should not be used by patients who are allergic to the drug leuprolide. Viadur should not be used by women or children and was not studied in women or children.
Viadur, like other similar medications, causes a temporary increase of testosterone in the blood during the first week of treatment. During this initial period, patients may experience worsening of symptoms or onset of new symptoms including bone pain, nervous system disturbances, blood in the urine, difficulty urinating, and spinal cord compression.
During treatment, the most common side effects reported throughout the body were hot flashes, lack of energy, breast enlargement, depression, and sweating. The most common side effects reported where the implant was inserted in the arm were bruising and burning.

See Your Healthcare Provider
Remember, your doctor or health care provider is the single best source of information regarding you and your health. Please consult your doctor if you have any questions about your health, your symptoms, or your medication.

This information does not take the place of your doctor’s advice or instructions but should help answer some of the questions you might have about prostate cancer therapies.


Distributed and Marketed by:

Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.